Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty

BACKGROUD: Intravenous tranexamic acid (TXA) has been shown to reduce blood loss in patients undergoing total joint arthroplasty without systemic complications. There is limited evidence of its effectiveness in revision procedures. This study evaluated intravenous TXA effect on blood loss, transfusi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gianakos, Arianna L., Saad, Bishoy N., Haring, Richard, Menken, Luke G., Elkattaway, Sherif, Liporace, Frank A., Yoon, Richard S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111901/
https://www.ncbi.nlm.nih.gov/pubmed/33975621
http://dx.doi.org/10.1186/s13037-021-00295-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111901/
https://www.ncbi.nlm.nih.gov/pubmed/33975621
http://dx.doi.org/10.1186/s13037-021-00295-5

Ejemplares similares